FutureGen Biopharmaceutical | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights

10 February 2026

Pivotal Claudin18.2 candidates keep coming

New pivotal trials will soon start for LaNova’s ADC and FutureGen’s MAb.

Subscribe to FutureGen Biopharmaceutical